Ticker Details
Natera, Inc. Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
IPO Date:	July 2, 2015
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$29.1B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.40 | 2.43%
Avg Daily Range (30 D):	$5.23 | 2.57%
Avg Daily Range (90 D):	$4.47 | 2.16%

Institutional Daily Volume
Avg Daily Volume:	.76M
Avg Daily Volume (30 D):	1.38M
Avg Daily Volume (90 D):	1.1M

Trade Size
Avg Trade Size (Sh.):	62
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	7,529
Avg Institutional Trade:	$5.63M
Avg Institutional Trade (30 D):	$9.45M
Avg Institutional Trade (90 D):	$11.6M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$11.88M
Avg Closing Trade (30 D):	$28.65M
Avg Closing Trade (90 D):	$32.74M
Avg Closing Volume:	129.02K

News

Apr 14, 2026 @ 6:30 PM Natera Positioned To Capture Growing $20 Billion M... Source: Vandana Singh

Mar 31, 2026 @ 4:48 PM Natera's Signatera Data Suggests Select Breast Can... Source: Vandana Singh

Feb 28, 2026 @ 9:37 AM 3 Reasons Exelixis Stock Could Deliver Marketâ€... Source: James Halley

Feb 22, 2026 @ 12:30 AM Billionaire Stanley Druckenmiller Is Betting Big o... Source: Lee Samaha

Jan 30, 2026 @ 9:57 AM Esoteric Testing Research Report 2026 - Global $41... Source: Researchandmarkets.Com

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.6	$.36	$-1.52
Diluted EPS	$-.6	$.36	$-1.52
Revenue	$696.64M	$665.5M	$2.31B
Gross Profit
Net Income / Loss	$-85.09M	$47.26M	$-208.16M
Operating Income / Loss	$-93.52M	$-22.79M	$-309.91M
Cost of Revenue
Net Cash Flow	$11.79M	$34.7M	$130.55M
PE Ratio